Although EphA2 loss of function impairs osteolysis, it is unclear if this effect is mediated by direct effects on osteoclast progenitors or indirectly through effects on other cell types, including tumor cells or other components of the bone microenvironment. The gene discussed is EPHA2; the disease is neoplasm.